Blood and Lymphatic Cancer: Targets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 52.0% | — | — | |
| 2024 | 4.9 | Q1 | 77.9% | — | — | |
| 2023 | 3.9 | Q2 | 65.9% | — | — | |
| 2022 | 2.8 | 39.8% | — | — | ||
| 2021 | — | 25.2% | — | — | ||
| 2018 | — | — | 0.124 | Q4 | 11.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1179-9889
country
NZ